Teleconferência de Resultados da Innospec (IOSP) do 3º Trimestre de 2026: Crescimento da Receita e Ganhos de Margem
A Innospec relatou crescimento no 3T26, com alta de 7% na receita, atingindo US$ 473,6 milhões, e expansão do EBITDA ajustado para US$ 51,4 milhões. O lucro operacional cresceu em todos os segmentos, liderado por Performance Chemicals. A empresa encerrou setembro com US$ 251,9 milhões em caixa, sem dívidas. O conselho elevou o dividendo anual em 9%. Para o 4T26, a administração projeta fluxo de caixa livre entre US$ 40 milhões e US$ 50 milhões. Os principais riscos incluem volatilidade de matérias-primas, atrasos operacionais no Oriente Médio e a recuperação gradual de volumes em Performance Chemicals.
A Innospec Inc. (NASDAQ: IOSP) relatou um crescimento amplo em sua teleconferência de resultados do 3T26, com alta na receita e no lucro operacional em todos os três segmentos de atuação. O segmento de Performance Chemicals liderou o avanço do lucro, enquanto a administração projeta que as melhorias na fábrica da Carolina do Norte e a retomada das atividades na divisão de Oilfield Services sustentem novos avanços.
Destaques
- A receita no 3T26 subiu 7% na comparação anual, atingindo US$ 473,6 milhões, enquanto a margem bruta expandiu 0,9 ponto percentual, para 27,3%.
- O EBITDA ajustado subiu de US$ 44,2 milhões para US$ 51,4 milhões. O LPA ajustado aumentou de US$ 1,12 para US$ 1,29.
- O lucro operacional de Performance Chemicals deu um salto de 84%, para US$ 16,9 milhões, com a margem bruta avançando para 18,8%, apesar da queda de 5% no volume.
- A receita de Oilfield Services cresceu 13% e o lucro operacional subiu 40%, embora atrasos nas atividades no Oriente Médio e custos elevados de matérias-primas tenham limitado o desempenho do trimestre.
- A Innospec encerrou setembro com US$ 251,9 milhões em caixa e equivalentes de caixa e sem dívidas. A gestão prevê entre US$ 40 milhões e US$ 50 milhões em fluxo de caixa livre no 4T26.
- O conselho de administração elevou o dividendo semestral para US$ 0,94 por ação, representando um aumento de 9% no dividendo anual.
Principais Resultados Financeiros
| Métrica | 3T26 | 3T25 | Variação |
|---|---|---|---|
| Receita | US$ 473,6 milhões | US$ 441,9 milhões | +7% |
| Margem bruta | 27,3% | 26,4% | +0,9 ponto percentual |
| EBITDA ajustado | US$ 51,4 milhões | US$ 44,2 milhões | Alta |
| Lucro líquido atribuível à Innospec | US$ 31,8 milhões | US$ 12,9 milhões | Alta |
| LPA GAAP | US$ 1,29 | US$ 0,52 | Alta |
| LPA ajustado | US$ 1,29 | US$ 1,12 | Alta |
| Fluxo de caixa operacional | US$ 17,4 milhões | — | Antes de US$ 15,6 milhões em despesas de capital |
| Caixa e equivalentes de caixa | US$ 251,9 milhões | — | Sem dívidas em 30 de setembro |
Desempenho Negocial e Operacional
Performance Chemicals
A receita subiu 6%, para US$ 180,5 milhões. A contribuição positiva de 12% vinda do preço e do mix de produtos, impulsionada pelo aumento nos preços das matérias-primas, compensou uma redução de 5% no volume e um impacto cambial negativo de 1%.
A margem bruta expandiu de 15,1% para 18,8%, e o lucro operacional avançou 84%, para US$ 16,9 milhões. A administração prevê concluir as melhorias de eficiência na fábrica da Carolina do Norte até o final do ano. As obras visam aumentar a capacidade, a produtividade e os rendimentos no segmento de cuidados pessoais e em outros produtos existentes.
A empresa não precisa requalificar os produtos junto aos clientes, mas a administração afirmou que a recuperação das vendas perdidas levará tempo. A expectativa é de que o crescimento siga uma trajetória ascendente gradual, em vez de uma recuperação brusca. A Innospec também planeja priorizar novas tecnologias e produtos de maior margem, em vez de preencher a unidade modernizada com commodities.
Fuel Specialties
A receita cresceu 5%, para US$ 180,7 milhões, sustentada por um aumento de 3% no volume e uma contribuição de 2% de preço e mix. A margem bruta foi de 31,5%, enquanto o lucro operacional subiu 1%, para US$ 35,6 milhões.
A administração informou que a divisão seguiu lidando com a volatilidade dos custos de matérias-primas e frete por meio de mecanismos contratuais de repasse de preços, embora esse repasse ocorra com certo atraso. A empresa classificou a Fuel Specialties como um negócio de margem estável e projeta a continuidade do forte desempenho e da demanda sazonal.
Oilfield Services
A receita subiu 13%, atingindo US$ 112,4 milhões. A margem bruta recuou 1,8 ponto percentual, para 28,2%, devido a um mix de vendas mais fraco, enquanto o lucro operacional avançou 40%, para US$ 6,7 milhões.
Volumes mais elevados provenientes da fábrica expandida de agentes redutores de arrasto sustentaram o crescimento. No entanto, atrasos nos negócios legados de produção e estimulação no Oriente Médio, somados aos custos elevados de matérias-primas, deixaram os resultados abaixo das expectativas da administração.
A administração afirmou que a demanda por agentes redutores de arrasto deve permanecer forte. O México continua sendo uma oportunidade potencial de longo prazo, mas a Innospec ainda não havia registrado vendas no país até o momento da teleconferência.
Orientação da Administração
- Os resultados do 4T26 para Performance Chemicals devem ser semelhantes aos do 3T26. A administração considera as melhorias na fábrica da Carolina do Norte cruciais para destravar o crescimento em 2027.
- A expectativa é de que o segmento de Oilfield Services apresente melhora sequencial no 4T26 à medida que a atividade dos clientes recomece a ser retomada no Oriente Médio.
- O nível de margem da Fuel Specialties no 4T26 deve permanecer amplamente alinhado ao do 3T26.
- A administração prevê um fluxo de caixa livre no 4T26 entre aproximadamente US$ 40 milhões e US$ 50 milhões, à medida que parte do investimento acumulado em capital de giro ao longo do ano for revertida.
- Em um cenário de relativa estabilidade nas matérias-primas, a empresa projeta que o fluxo de caixa livre se aproxime da faixa de US$ 55 milhões a US$ 60 milhões em 2027, exigindo menor necessidade de investimento em capital de giro.
- As despesas de capital para 2026 estão estimadas em aproximadamente US$ 60 milhões.
Riscos e Pontos de Atenção
As condições de segurança no Oriente Médio atrasaram as atividades de campo nas operações legadas de Oilfield Services da Innospec. O ritmo de recuperação depende do retorno das sondas ao trabalho e da capacidade da empresa de retomar o atendimento aos clientes.
O capital de giro expandiu cerca de US$ 80 milhões desde o início do ano devido ao crescimento dos negócios, à inflação de matérias-primas e frete e ao aumento nos estoques. A gestão reconheceu que os estoques podem estar acima do nível ideal e que os contas a receber exigem um controle mais rigoroso.
Os volumes do segmento de Performance Chemicals permaneceram inferiores na comparação anual. Embora as obras de melhoria na Carolina do Norte estejam dentro do cronograma, a administração espera que a recuperação de clientes e vendas seja gradual.
A volatilidade das matérias-primas e dos fretes continua sendo relevante para a Fuel Specialties. Os mecanismos contratuais de repasse ajudam a administrar esses custos, mas apresentam uma defasagem temporal.
Destaques da Sessão de Perguntas e Respostas
Os analistas focaram nas interrupções no Oriente Médio, na modernização da unidade da Carolina do Norte, no repasse de preços e na geração de caixa.
A administração afirmou que os transtornos no Oriente Médio afetaram principalmente os trabalhos de produção e estimulação, e não o negócio de agentes redutores de arrasto. O impacto financeiro não foi descrito como um percentual significativo dos resultados do segmento, mas foi suficiente para afetar o desempenho de Oilfield Services.
Em relação a Performance Chemicals, a gestão confirmou que o cronograma das obras não sofreu alterações relevantes. A prioridade inicial foi a restauração do fornecimento de produtos, seguida por melhorias de eficiência, rendimento, capacidade e adaptação ao inverno. Nenhuma requalificação junto aos clientes é necessária.
Sobre o fluxo de caixa, a administração prevê uma melhora significativa no 4T26 com a normalização do capital de giro. O balanço desalavancado da Innospec proporciona flexibilidade para investimentos orgânicos, aquisições, crescimento de dividendos e recompra de ações.
Transcrição Completa da Teleconferência de Resultados
Transcrição completa da teleconferência de resultados
Comentários da administração
Operator
Good day, and thank you for standing by. Welcome to the Innospec's Third Quarter 2026 Earnings Release and Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, David Jones, General Counsel and Chief Compliance Officer. Please go ahead.
David Jones
Thank you. Welcome to Innospec's quarterly earnings call. This is David Jones, and I'm Innospec's General Counsel and Chief Compliance Officer. The earnings release for the quarter and this presentation are posted on the company's website.
During this call, we will make forward-looking statements, which are predictions and projections about future events. These statements are based on current expectations and assumptions that are subject to risks and uncertainties that could cause actual results to differ materially from the anticipated results implied by such forward-looking statements. The risks and uncertainties are detailed in Innospec's filings with the SEC. Please see the SEC site and Innospec's site for these and related documents.
In today's presentation, we've also included non-GAAP financial measures. A reconciliation to the most directly comparable GAAP financial measure is contained in the earnings release. The non-GAAP financial measures should not be considered as a substitute for those prepared in accordance with GAAP. They are included as additional items to aid investor understanding of the company's performance and anticipated impact that these items and events had on financial results.
With me today from Innospec are Patrick Williams, President and Chief Executive Officer; and Ian Cleminson, Executive Vice President and Chief Financial Officer. And with that, I'll turn it over to you, Patrick.
Patrick Williams
Thank you, David, and welcome, everyone, to Innospec's Third Quarter 2026 Conference Call. This was a strong quarter for Innospec with all businesses delivering sales growth and operating income improvement. Performance Chemicals sales growth and gross margin improvement drove an 84% operating income increase over last year. The North Carolina plant efficiency upgrades discussed last quarter are scheduled to be completed by year-end. These upgrades will increase capacity, productivity and yields on a wide range of existing personal care and other products.
In parallel, we will continue to focus on commercializing new products to drive further margin and operating income improvement in the coming quarters.
Fuel Specialties had another strong quarter, delivering revenue and operating income growth with margins in our target range. Both volume and price/mix improved as the business has continued to manage well against raw material volatility. We expect continued strong performance and seasonal demand in the coming quarters.
Oilfield Services operating income grew 40% and operating margins expanded driven by improved volumes from our recent DRA plant expansion. Third quarter results were lower than expected on activity delays in our Middle East legacy business, along with elevated raw material costs. We expect sequential improvement in the fourth quarter.
Now I will turn the call over to Ian Cleminson, who will review our financial results in more detail. Then I will return with some concluding comments. After that, Ian and I will take your questions. Ian?
Ian Cleminson
Thanks, Patrick. Turning to Slide 7 in the presentation. The company's total revenues for the third quarter were $473.6 million, a 7% increase from $441.9 million a year ago. Overall gross margin increased by 0.9 percentage points from last year to 27.3%.
Adjusted EBITDA for the quarter was $51.4 million compared to $44.2 million last year, and net income attributable to Innospec for the quarter was $31.8 million compared to $12.9 million a year ago.
Our GAAP earnings per share were $1.29, and there was no net impact of special items in the quarter.
Last year, we reported GAAP earnings per share of $0.52, which included a negative impact from special items of $0.60 per share. Excluding special items in both years, our adjusted EPS for the quarter was $1.29 compared to $1.12 a year ago.
Turning to Slide 8. Revenues in Performance Chemicals for the third quarter were $180.5 million, up 6% from last year's $170.8 million. Volume reductions of 5% and a negative currency impact of 1% were offset by a positive price/mix of 12%, driven by higher raw material pricing.
Gross margins of 18.8% increased 3.7 percentage points compared to 15.1% in the same quarter in 2025.
Operating income of $16.9 million increased 84% from $9.2 million last year. We expect the fourth quarter results to be similar to this quarter with the plant upgrades in North Carolina the key to unlocking growth in 2027.
Moving on to Slide 9. Revenues in Fuel Specialties for the third quarter were $180.7 million, up 5% from $172 million reported a year ago. Volumes were up 3% with price/mix up 2%.
Fuel Specialties gross margins of 31.5% decreased 0.5 percentage points compared to 35.6% in the same quarter last year.
Operating income of $35.6 million was up 1% from $35.3 million a year ago.
Moving on to Slide 10. Revenues in Oilfield Services for the quarter were $112.4 million, up 13% from the $99.1 million reported a year ago.
Gross margins of 28.2% decreased 1.8 percentage points from last year's 30% on a weaker sales mix.
Operating income of $6.7 million increased 40% from $4.8 million 1 year ago.
Turning to Slide 11. Corporate costs for the quarter were $18.6 million compared with $18.2 million a year ago. The adjusted effective tax rate for the quarter was 24.7% compared to 22.7% last year.
Moving on to Slide 12. Cash from operating activities was $17.4 million before capital expenditures of $15.6 million. As of September 30, Innospec had $251.9 million in cash and cash equivalents and no debt.
And now I'll turn it back over to Patrick for some final comments. Patrick?
Patrick Williams
Thanks, Ian. Again, this quarter, Innospec delivered strong sales and operating income growth with higher margins. Performance Chemicals and Oilfield Services remain our key focus. We expect continued steady and strong results in Fuel Specialties. Operating cash generation was positive in the quarter, and our net cash position remained at over $250 million. We continue to focus on driving increased operating cash flow in the coming quarters with better working capital efficiency.
We have significant balance sheet flexibility for organic investment, M&A, dividend growth and buybacks. This quarter, our Board approved a further increase in our semiannual dividend to $0.94 per share, resulting in an annual dividend increase of 9%.
Now I will turn the call over to the operator, and Ian and I will take your questions.
Operator
[Operator Instructions] We are now going to take our first question, and this one comes from Jon Tanwanteng from CJS Securities.
Perguntas e respostas
Jonathan Tanwanteng
I was wondering if you could quantify the impact in the oilfield business from delays in the Mid East. And I'm assuming that, that was pipeline attacks in Saudi, number one, in the quarter? And number two, how you expect that business to trend in Q4, assuming a recovery there and the underlying inflation dynamics?
Patrick Williams
Yes, Jon, it's Patrick. It wasn't necessarily impacting the DRA business. More of the impact was on production and stim, and it's just the fact of getting people out in the fields to work while you're having drones bombing over the top of you has been a very difficult situation for that whole area. And the key for us really is making sure that we're back on these rigs when they go back out and that we're servicing the way they need to be serviced.
The impact is probably -- it was probably not a significant percentage, but big enough to make a difference in oilfield. And the hope is from what we're seeing as long as we service the customers as we expect and we have the technology is that we're starting to see some return in business in the fourth quarter, which should really help us out moving forward.
Jonathan Tanwanteng
Got it. And as you head into '27, could you just update us on the outlook for the segment in the coming year, especially if you have potential customers coming in from Latin America and as the dynamic evolves from pipelines to maybe a reopening of the Strait or some other condition change in the Middle East?
Patrick Williams
Yes. So I'll work backwards. If we just stick with the Middle East for a minute, I think that with everything that's going on in that area and other businesses that we're going after, our DRA should remain strong even if the Strait and we have settlements for the Strait of Hormuz than we move forward.
If you look at the general business, we're still waiting to see things move in Latin America. Specific to Mexico, I think you've seen some announcements by President Shinbaum about opening up and putting more money into petrochemicals and petrochemical facilities. And to do that, they've got to fix their crude issue. We're hoping at some time that, that turns, but we have not had any sales into Mexico to date. So it's -- if we had the crystal ball, if all these things came into place, it would obviously look a lot different than it is today. But we still see significant growth -- sequential growth as well moving forward and not [indiscernible] quarter, but in the quarters moving forward in 2027.
Jonathan Tanwanteng
Okay. Great. Next for me, just could you just update us on your expectations for cash and cash flow? You've come down in your net cash balance over the past year. And recognizing you've returned a lot of cash to shareholders, a great job there. But I was wondering if you had any thoughts on where your net cash balance is going to be over the coming year, and how you expect the spending priorities to change, if at all?
Ian Cleminson
Yes. Let me take that one, Jon, it's Ian. What we've seen so far year-to-date is quite a large investment in our working capital. That's expanded by about $80 million since the start of the year. In the fourth quarter, we expect some of that to reverse. And what's driven that is partly the expansion of the business and partly some of the inflation that we've seen coming through the supply chain in terms of raw materials and freights, and that's worked itself through. But no doubt, we're probably carrying a little bit too much inventory. We can be a little bit tighter on some of those receivables. So we've got some work to do in the fourth quarter.
Our view is that we will be much more cash generative in the fourth quarter to the region of about $40 million to $50 million at the free cash flow level. So that takes care of this year. And as we roll into next year, our expectation is that we won't need -- on a stable background with raw materials, relatively stable, we won't need the same level of working capital investment. So we would imagine that we'll be hitting closer to $55 million to $60 million of free cash flow next year. And that's based on a pretty similar level of capital expenditure, around about $60 million last year, and we expect about $60 million this year as well.
Operator
We are now going to take our next question, and this one is from Mike Harrison from Seaport Research Partners.
Michael Harrison
Apologies if I missed it, but a couple of questions on personal care. It sounds like you're expecting the North Carolina plant upgrades to be complete by year-end. I'm just wondering, has the timing moved later there? And if so, what's causing the delays? And I guess the other piece of that question is, is there a requalification process that you need to go through with your customers? Or should we see sales volumes kind of getting back to normal by Q1?
Patrick Williams
Yes, Mike, it's Patrick. We haven't really -- the timing has been about what we expected. The number one priority was to get the plants up and running so that we could provide products to our customers, and that's what we did. The secondary part of the plan was to make sure that we concluded and finished the efficiencies of the plant to make it better, better yields, providing more volume because you have better yields, et cetera, winterizing it, all the things that we had to do. Our number one priority was to get product to our customers. And so the timing of that is exactly what we thought that we would complete all of this by the fourth quarter, and that should happen.
So in regards to recapturing more products or lost sales, I should say, it's going to take some time. We don't have to requalify, but it is going to take some time to go back and recapture some of that business. And that's why we see this -- we do see sequential growth moving forward, but it's just -- it's not going to be that big spike. It's going to be a nice slow curve upwards. And I think the other thing that we're focusing on, too, is the product mix that we put on that plan. We don't want to just load it up with commodity products. We want new products, new technologies that require or we get higher margins from, and that's really the plan moving forward. So it's a plan we've had in place. We're sticking to it. I think the strategy is working, and it should work moving forward in 2027.
Michael Harrison
All right. Very helpful. And then my other question is on the Fuel Specialties business. You guys have these contractual pricing pass-throughs. It looks like price was only up about 2% year-on-year despite what I assume was pretty meaningful raw material inflation. I was just hoping you could talk a little bit about the timing of that pricing pass-through and how that's impacting the margins, either gross margin or operating margin as you look at Fuel Specialties for Q3 and Q4?
Ian Cleminson
Yes, Mike, I'll take that one. We think the Fuel Specialties team has done a good job actually. They've been battling against some really volatile raw material pricing and freight pricing as well. We have managed the gross margins in that business really well. We are 0.5 percentage point down year-over-year. And as you know, we've got all the mechanisms in place as raw materials come through, and there's a little bit of a lag in there. So the level we're at in the fourth (sic) [ third ] quarter is the level we expect to be at in the fourth quarter. We don't see much change there. We think the business has got a handle on it, and we're in control of all of that. So we don't -- I take your point that the price/mix is not up that much, but it's certainly at the gross margin level and the gross profit dollars and the operating income level and the operating margin levels, we're happy where the business is at.
Patrick Williams
And I think, Mike, just to add a little color to what Ian said. I started out with this business and ran this business for quite some time. And we have seen these markets up and down. We've seen high inflation. We've seen recessions. We've seen mega market movements. And it's never been these big run-ups on margins or big rundown on margins. It's always a very well managed and a lot of it's contracts, but it's a very well-managed margin business. So you're never going to see these big spikes in that business. It's just a very stable business, and we've seen that for as long as we've been ahead.
Operator
There are no further questions for today. I will now hand the call back to Patrick Williams for closing remarks.
Patrick Williams
Thank you all for joining us today, and thanks to all our shareholders, customers and Innospec employees for your interest and support. If you have any further questions about Innospec or matters discussed today, please give us a call. We look forward to meeting up with you again to discuss our fourth quarter 2026 results in February. Have a great day.
Operator
Thank you. This concludes today's conference call. Thank you for participating. You may now disconnect.
Este artigo pode conter conteúdo gerado ou traduzido por IA, revisado por humanos, destinado apenas para referência e informações gerais, não constituindo recomendação de investimento.
Artigos recomendados










Comentários (0)
Clique no botão $, digite o código do ativo e selecione para vincular uma ação, ETF ou outro ticker.